🎙️ What does the future hold for people living with NMOSD and MOGAD? With new treatments emerging and research advancing, there are important reasons for hope. As part of Patient Community Day 2026, we're pleased to share the second episode in our two-part ECTRIMS Podcast series, exploring the latest research and the perspectives of people living with MS and related neurological conditions. Host Brett Drummond sits down with Taylor Ann Macey, Director of Patient Engagement at the Sumaira Foundation who lives with NMOSD, and Dr Eoin Flanagan, Professor of Neurology at Mayo Clinic, for a conversation about scientific progress and lived experience. <ul> <li>What are the challenges of living with a rare neuroimmune condition?</li> <li>How are new treatments changing the outlook for NMOSD and MOGAD?</li> <li>And why are the involvement of people with lived experienceand so important in shaping future research?</li> </ul> From the isolation that can come with a rare diagnosis to the growing optimism around treatment and research, this conversation highlights both the challenges and the possibilities ahead. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

🎙️ What does the future hold for people living with NMOSD and MOGAD? With new treatments emerging and research advancing, there are important reasons for hope. As part of Patient Community Day 2026, we're pleased to share the second episode in our two-part ECTRIMS Podcast series, exploring the latest research and the perspectives of people living with MS and related neurological conditions. Host Brett Drummond sits down with Taylor Ann Macey, Director of Patient Engagement at the Sumaira Foundation who lives with NMOSD, and Dr Eoin Flanagan, Professor of Neurology at Mayo Clinic, for a conversation about scientific progress and lived experience. What are the challenges of living with a rare neuroimmune condition? How are new treatments changing the outlook for NMOSD and MOGAD? And why are the involvement of people with lived experienceand so important in shaping future research? From the isolation that can come with a rare diagnosis to the growing optimism around treatment and research, this conversation highlights both the challenges and the possibilities ahead. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

NMOSD & MOGAD: New Treatments and Hope for the Future | Patient Community Day 2026 (Part 2)

What does the MS community need from research – and how can we make sure the voices of people living with MS help shape what comes next? As part of Patient Community Day 2026, we're sharing a special collaborative episode from RealTalk MS and the ECTRIMS Podcast, hosted by Jon Strum. Jon is joined by Karen Jacoby, MS advocate and person living with MS, and Peter Feys, Professor of Rehabilitation Sciences and Neurorehabilitation at Hasselt University – for a conversation that puts the patient perspective at the centre – exploring the relationship between research, lived experience and the priorities that matter to people affected by MS. Recorded at Patient Community Day in Toronto, the episode forms part of the wider conversations taking place during the 10th Joint ACTRIMS-ECTRIMS Meeting – but this one is specifically for, and about, the MS community. This episode was produced and hosted by RealTalk MS – a Supporting Partner of Patient Community Day – and is being shared across ECTRIMS channels with permission from Jon Strum to help the conversation reach as many people as possible. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

What does the MS community need from research – and how can we make sure the voices of people living with MS help shape what comes next? As part of Patient Community Day 2026, we're sharing a special collaborative episode from RealTalk MS and the ECTRIMS Podcast, hosted by Jon Strum. Jon is joined by Karen Jacoby, MS advocate and person living with MS, and Peter Feys, Professor of Rehabilitation Sciences and Neurorehabilitation at Hasselt University – for a conversation that puts the patient perspective at the centre – exploring the relationship between research, lived experience and the priorities that matter to people affected by MS. Recorded at Patient Community Day in Toronto, the episode forms part of the wider conversations taking place during the 10th Joint ACTRIMS-ECTRIMS Meeting – but this one is specifically for, and about, the MS community. This episode was produced and hosted by RealTalk MS – a Supporting Partner of Patient Community Day – and is being shared across ECTRIMS channels with permission from Jon Strum to help the conversation reach as many people as possible. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

What does the MS community need from research – and how can we make sure the voices of people living with MS help shape what comes next? As part of Patient Community Day 2026, we're sharing a special collaborative episode from RealTalk MS and the ECTRIMS Podcast, hosted by Jon Strum. Jon is joined by Karen Jacoby, MS advocate and person living with MS, and Peter Feys, Professor of Rehabilitation Sciences and Neurorehabilitation at Hasselt University – for a conversation that puts the patient perspective at the centre – exploring the relationship between research, lived experience and the priorities that matter to people affected by MS. Recorded at Patient Community Day in Toronto, the episode forms part of the wider conversations taking place during the 10th Joint ACTRIMS-ECTRIMS Meeting – but this one is specifically for, and about, the MS community. This episode was produced and hosted by RealTalk MS – a Supporting Partner of Patient Community Day – and is being shared across ECTRIMS channels with permission from Jon Strum to help the conversation reach as many people as possible. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

MS Research: What's New and What Matters to Patients? | Patient Community Day 2026 (Part 1)

Three days of science, debate and discovery. For the final episode in our special MSToronto2026 podcast series, ECTRIMS Executive Committee member Jaume Sastre-Garriga joins host Brett Drummond direct from Toronto. Together, they unpack the key insights from Day Three, including the Late Breaking Abstract session, before stepping back to reflect on the Joint Meeting as a whole. What stood out across the week? Which developments and conversations could have lasting significance? And as thousands of researchers and clinicians prepare to leave Toronto, what comes next for the MS field? Recorded at the 10th Joint ACTRIMS-ECTRIMS Meeting, this is our final dispatch from Toronto – bringing together the science, conversations and ideas that shaped an extraordinary week. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Three days of science, debate and discovery. For the final episode in our special MSToronto2026 podcast series, ECTRIMS Executive Committee member Jaume Sastre-Garriga joins host Brett Drummond direct from Toronto. Together, they unpack the key insights from Day Three, including the Late Breaking Abstract session, before stepping back to reflect on the Joint Meeting as a whole. What stood out across the week? Which developments and conversations could have lasting significance? And as thousands of researchers and clinicians prepare to leave Toronto, what comes next for the MS field? Recorded at the 10th Joint ACTRIMS-ECTRIMS Meeting, this is our final dispatch from Toronto – bringing together the science, conversations and ideas that shaped an extraordinary week. This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

MSToronto2026 Day Three: What Will We Take Away from Toronto?

Today, our special podcast series brings together two major voices from the North American MS community: <ul> <li>Tim Coetzee, National Multiple Sclerosis Society</li> <li>Pamela Valentine, MS Canada</li> </ul> Scientific progress in MS is accelerating. But is that progress reaching the people who need it? Alongside their reflections on the key takeaways and conversations from Day Two of MSToronto2026, Tim and Pamela join host Brett Drummond to look beyond individual studies and ask some bigger questions about where the MS field goes next. Where does the MS community need progress most urgently? How can researchers, clinicians, patient organisations and people affected by MS work together more effectively? And how do we make sure scientific advances ultimately translate into meaningful change in people's lives? This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Today, our special podcast series brings together two major voices from the North American MS community: Tim Coetzee, National Multiple Sclerosis Society Pamela Valentine, MS Canada Scientific progress in MS is accelerating. But is that progress reaching the people who need it? Alongside their reflections on the key takeaways and conversations from Day Two of MSToronto2026, Tim and Pamela join host Brett Drummond to look beyond individual studies and ask some bigger questions about where the MS field goes next. Where does the MS community need progress most urgently? How can researchers, clinicians, patient organisations and people affected by MS work together more effectively? And how do we make sure scientific advances ultimately translate into meaningful change in people's lives? This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

MSToronto2026 Day Two: What Does the MS Community Need Next?

Day One at MSToronto2026 – and we're taking you inside one of the meeting's headline lectures. Our special MSToronto2026 podcast series continues with Daniel Reich – the MSToronto2026 Lecturer – as he joins host Brett Drummond to reflect on some of the key takeaways from the first full day in Toronto. Then, we go deeper. What if imaging could help us connect the dots in MS - from disease mechanisms to networks to the person living with MS? Fresh from his lecture, Unifying Multiple Sclerosis: Imaging from Teams to Tissue to Biology, Daniel takes the conversation beyond the stage: · What can imaging reveal about the biology driving MS? · How is it changing the way we understand what is happening in the brain? · And where could the next generation of imaging take MS research? Recorded direct from Toronto, our MSToronto2026 series is only getting started. Follow the ECTRIMS Podcast as we bring you new conversations and highlights direct from Toronto throughout the Joint Meeting. --- This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Day One at MSToronto2026 – and we're taking you inside one of the meeting's headline lectures. Our special MSToronto2026 podcast series continues with Daniel Reich – the MSToronto2026 Lecturer – as he joins host Brett Drummond to reflect on some of the key takeaways from the first full day in Toronto. Then, we go deeper. What if imaging could help us connect the dots in MS - from disease mechanisms to networks to the person living with MS? Fresh from his lecture, Unifying Multiple Sclerosis: Imaging from Teams to Tissue to Biology, Daniel takes the conversation beyond the stage: · What can imaging reveal about the biology driving MS? · How is it changing the way we understand what is happening in the brain? · And where could the next generation of imaging take MS research? Recorded direct from Toronto, our MSToronto2026 series is only getting started. Follow the ECTRIMS Podcast as we bring you new conversations and highlights direct from Toronto throughout the Joint Meeting. --- This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Day One at MSToronto2026 – and we're taking you inside one of the meeting's headline lectures. Our special MSToronto2026 podcast series continues with Daniel Reich – the MSToronto2026 Lecturer – as he joins host Brett Drummond to reflect on some of the key takeaways from the first full day in Toronto. Then, we go deeper. What if imaging could help us connect the dots in MS - from disease mechanisms to networks to the person living with MS? Fresh from his lecture, Unifying Multiple Sclerosis: Imaging from Teams to Tissue to Biology, Daniel takes the conversation beyond the stage: · What can imaging reveal about the biology driving MS? · How is it changing the way we understand what is happening in the brain? · And where could the next generation of imaging take MS research? Recorded direct from Toronto, our MSToronto2026 series is only getting started. Follow the ECTRIMS Podcast as we bring you new conversations and highlights direct from Toronto throughout the Joint Meeting. --- This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Day One Highlights: From Imaging to Biology with Daniel Reich

Listen to Brenda Banwell – the ECTRIMS 2022 Keynote Lecturer – deep dive into the key takeaways of the first day of ECTRIMS 2022.

Listen to Brenda Banwell – the ECTRIMS 2022 Keynote Lecturer – deep dive into the key takeaways of the first day of ECTRIMS 2022.

Day One Highlights of ECTRIMS 2022

Welcome to the ECTRIMS podcast, the new sounding board for the MS research community. Tune in on the 27th, 28th and 29th of October for the official debut of The ECTRIMS Podcast. Enjoy back-to-back episodes of each day of congress, and stay up to date on all the key happenings unfolding at the world's largest international congress for MS research.

Welcome to the ECTRIMS podcast, the new sounding board for the MS research community. Tune in on the 27th, 28th and 29th of October for the official debut of The ECTRIMS Podcast. Enjoy back-to-back episodes of each day of congress, and stay up to date on all the key happenings unfolding at the world's largest international congress for MS research.

NEW! The ECTRIMS Podcast

The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.

Science

Medicine

Health & Fitness

The ECTRIMS Podcast is a sounding board for MS experts &amp; advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote &amp; nurture the advancement of research.

Share The ECTRIMS Podcast

Sign up to save your podcasts

The ECTRIMS Podcast

The ECTRIMS Podcast episodes

About The ECTRIMS Podcast

Best of The ECTRIMS Podcast

More shows like The ECTRIMS Podcast

Neurology® Podcast

Practical Neurology Podcast

In The Dark

The Daily

RealTalk MS

Shameless

Living Well with Multiple Sclerosis

Post Reports

The Journal.

MS Living Well: Key Info from Multiple Sclerosis Experts

ZOE Science & Nutrition

Continuum Audio